25 XP   0   0   10

Vaxart Inc
Buy, Hold or Sell?

Let's analyse Vaxart together

PenkeI guess you are interested in Vaxart Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vaxart Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vaxart Inc

I send you an email if I find something interesting about Vaxart Inc.

Quick analysis of Vaxart (30 sec.)










What can you expect buying and holding a share of Vaxart? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.33
Expected worth in 1 year
$0.03
How sure are you?
31.7%

+ What do you gain per year?

Total Gains per Share
$-0.30
Return On Investment
-23.4%

For what price can you sell your share?

Current Price per Share
$1.30
Expected price per share
$1.03 - $1.725
How sure are you?
50%

1. Valuation of Vaxart (5 min.)




Live pricePrice per Share (EOD)

$1.30

Intrinsic Value Per Share

$-4.66 - $-2.27

Total Value Per Share

$-4.32 - $-1.94

2. Growth of Vaxart (5 min.)




Is Vaxart growing?

Current yearPrevious yearGrowGrow %
How rich?$57.8m$135.5m-$59.5m-78.3%

How much money is Vaxart making?

Current yearPrevious yearGrowGrow %
Making money-$20.6m-$26.9m$6.3m30.7%
Net Profit Margin-2,387.1%-34,562.2%--

How much money comes from the company's main activities?

3. Financial Health of Vaxart (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#464 / 1031

Most Revenue
#431 / 1031

Most Profit
#735 / 1031

Most Efficient
#879 / 1031

What can you expect buying and holding a share of Vaxart? (5 min.)

Welcome investor! Vaxart's management wants to use your money to grow the business. In return you get a share of Vaxart.

What can you expect buying and holding a share of Vaxart?

First you should know what it really means to hold a share of Vaxart. And how you can make/lose money.

Speculation

The Price per Share of Vaxart is $1.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vaxart.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vaxart, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.33. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vaxart.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-7.7%-0.12-9.1%-0.15-11.9%-0.09-6.9%-0.06-4.5%
Usd Book Value Change Per Share-0.08-6.1%-0.08-5.8%-0.11-8.5%0.011.0%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-6.1%-0.08-5.8%-0.11-8.5%0.011.0%0.00-0.1%
Usd Price Per Share0.57-0.70-2.92-3.43-2.75-
Price to Earnings Ratio-1.43--1.51--4.72--16.18--42,520.22-
Price-to-Total Gains Ratio-7.26--12.59--25.01-25.46--21.34-
Price to Book Ratio1.72-1.63-3.53-7.64-26,144.13-
Price-to-Total Gains Ratio-7.26--12.59--25.01-25.46--21.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.3
Number of shares769
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.080.01
Usd Total Gains Per Share-0.080.01
Gains per Quarter (769 shares)-58.3810.30
Gains per Year (769 shares)-233.5041.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-234-24404131
20-467-47808272
30-701-7120124113
40-934-9460165154
50-1168-11800206195
60-1401-14140247236
70-1635-16480288277
80-1868-18820330318
90-2102-21160371359
100-2335-23500412400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%4.037.00.09.8%55.084.00.039.6%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%13.028.00.031.7%67.071.01.048.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.041.00.0%0.00.0139.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%13.028.00.031.7%67.071.01.048.2%

Fundamentals of Vaxart

About Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical dysplasia. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-03-22 07:28:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vaxart Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vaxart earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • A Net Profit Margin of -262.3% means that $-2.62 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vaxart Inc:

  • The MRQ is -262.3%. The company is making a huge loss. -2
  • The TTM is -2,387.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-262.3%TTM-2,387.1%+2,124.9%
TTM-2,387.1%YOY-34,562.2%+32,175.0%
TTM-2,387.1%5Y-10,944.3%+8,557.1%
5Y-10,944.3%10Y-6,198.5%-4,745.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-262.3%-159.2%-103.1%
TTM-2,387.1%-202.3%-2,184.8%
YOY-34,562.2%-263.0%-34,299.2%
5Y-10,944.3%-452.4%-10,491.9%
10Y-6,198.5%-589.0%-5,609.5%
1.1.2. Return on Assets

Shows how efficient Vaxart is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • -18.9% Return on Assets means that Vaxart generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vaxart Inc:

  • The MRQ is -18.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.9%TTM-18.3%-0.6%
TTM-18.3%YOY-15.3%-3.0%
TTM-18.3%5Y-12.2%-6.0%
5Y-12.2%10Y-11.0%-1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.9%-12.5%-6.4%
TTM-18.3%-12.2%-6.1%
YOY-15.3%-11.2%-4.1%
5Y-12.2%-13.3%+1.1%
10Y-11.0%-14.6%+3.6%
1.1.3. Return on Equity

Shows how efficient Vaxart is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • -30.1% Return on Equity means Vaxart generated $-0.30 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vaxart Inc:

  • The MRQ is -30.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.1%TTM-27.2%-2.8%
TTM-27.2%YOY-20.3%-6.9%
TTM-27.2%5Y-19.7%-7.5%
5Y-19.7%10Y-19.6%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.1%-16.0%-14.1%
TTM-27.2%-15.8%-11.4%
YOY-20.3%-13.9%-6.4%
5Y-19.7%-18.2%-1.5%
10Y-19.6%-19.1%-0.5%

1.2. Operating Efficiency of Vaxart Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vaxart is operating .

  • Measures how much profit Vaxart makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vaxart Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,296.2%+2,296.2%
TTM-2,296.2%YOY-29,239.3%+26,943.1%
TTM-2,296.2%5Y-9,544.7%+7,248.5%
5Y-9,544.7%10Y-5,488.4%-4,056.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM-2,296.2%-208.5%-2,087.7%
YOY-29,239.3%-280.2%-28,959.1%
5Y-9,544.7%-459.9%-9,084.8%
10Y-5,488.4%-596.9%-4,891.5%
1.2.2. Operating Ratio

Measures how efficient Vaxart is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.55 means that the operating costs are $3.55 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vaxart Inc:

  • The MRQ is 3.551. The company is inefficient in keeping operating costs low. -1
  • The TTM is 33.752. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.551TTM33.752-30.201
TTM33.752YOY378.871-345.119
TTM33.7525Y120.792-87.041
5Y120.79210Y103.777+17.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5512.817+0.734
TTM33.7523.181+30.571
YOY378.8713.609+375.262
5Y120.7925.554+115.238
10Y103.7777.396+96.381

1.3. Liquidity of Vaxart Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vaxart is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.32 means the company has $3.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vaxart Inc:

  • The MRQ is 3.318. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.588. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.318TTM4.588-1.270
TTM4.588YOY8.428-3.840
TTM4.5885Y7.691-3.102
5Y7.69110Y7.037+0.653
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3183.987-0.669
TTM4.5884.440+0.148
YOY8.4285.569+2.859
5Y7.6916.158+1.533
10Y7.0376.492+0.545
1.3.2. Quick Ratio

Measures if Vaxart is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • A Quick Ratio of 0.58 means the company can pay off $0.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vaxart Inc:

  • The MRQ is 0.580. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 4.941. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.580TTM4.941-4.361
TTM4.941YOY10.693-5.751
TTM4.9415Y8.419-3.478
5Y8.41910Y8.032+0.387
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5803.653-3.073
TTM4.9414.158+0.783
YOY10.6935.515+5.178
5Y8.4196.012+2.407
10Y8.0326.206+1.826

1.4. Solvency of Vaxart Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vaxart assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vaxart to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37 means that Vaxart assets are financed with 37.1% credit (debt) and the remaining percentage (100% - 37.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vaxart Inc:

  • The MRQ is 0.371. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.327. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.327+0.043
TTM0.327YOY0.241+0.086
TTM0.3275Y0.320+0.007
5Y0.32010Y0.343-0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.336+0.035
TTM0.3270.330-0.003
YOY0.2410.267-0.026
5Y0.3200.367-0.047
10Y0.3430.378-0.035
1.4.2. Debt to Equity Ratio

Measures if Vaxart is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vaxart to the Biotechnology industry mean.
  • A Debt to Equity ratio of 58.9% means that company has $0.59 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vaxart Inc:

  • The MRQ is 0.589. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.489. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.589TTM0.489+0.100
TTM0.489YOY0.324+0.164
TTM0.4895Y0.598-0.110
5Y0.59810Y0.689-0.091
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5890.376+0.213
TTM0.4890.398+0.091
YOY0.3240.334-0.010
5Y0.5980.431+0.167
10Y0.6890.476+0.213

2. Market Valuation of Vaxart Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vaxart generates.

  • Above 15 is considered overpriced but always compare Vaxart to the Biotechnology industry mean.
  • A PE ratio of -1.43 means the investor is paying $-1.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vaxart Inc:

  • The EOD is -3.252. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.433. Based on the earnings, the company is expensive. -2
  • The TTM is -1.508. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.252MRQ-1.433-1.819
MRQ-1.433TTM-1.508+0.075
TTM-1.508YOY-4.719+3.211
TTM-1.5085Y-16.181+14.673
5Y-16.18110Y-42,520.222+42,504.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.252-2.697-0.555
MRQ-1.433-2.422+0.989
TTM-1.508-2.709+1.201
YOY-4.719-4.116-0.603
5Y-16.181-6.257-9.924
10Y-42,520.222-6.478-42,513.744
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vaxart Inc:

  • The EOD is -4.211. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.856. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.763. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.211MRQ-1.856-2.356
MRQ-1.856TTM-1.763-0.093
TTM-1.763YOY-4.826+3.063
TTM-1.7635Y-49.366+47.604
5Y-49.36610Y301,865.726-301,915.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.211-3.344-0.867
MRQ-1.856-2.939+1.083
TTM-1.763-3.486+1.723
YOY-4.826-5.592+0.766
5Y-49.366-8.464-40.902
10Y301,865.726-8.872+301,874.598
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vaxart is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.72 means the investor is paying $1.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vaxart Inc:

  • The EOD is 3.910. Based on the equity, the company is fair priced.
  • The MRQ is 1.723. Based on the equity, the company is underpriced. +1
  • The TTM is 1.628. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.910MRQ1.723+2.187
MRQ1.723TTM1.628+0.094
TTM1.628YOY3.532-1.904
TTM1.6285Y7.638-6.010
5Y7.63810Y26,144.130-26,136.492
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9102.198+1.712
MRQ1.7232.042-0.319
TTM1.6282.121-0.493
YOY3.5322.907+0.625
5Y7.6383.682+3.956
10Y26,144.1304.114+26,140.016
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vaxart Inc.

3.1. Institutions holding Vaxart Inc

Institutions are holding 18.146% of the shares of Vaxart Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc4.59230.00017044971881311.2668
2023-12-31Geode Capital Management, LLC1.2790.000119620331753989.8172
2023-12-31BlackRock Inc1.16650178946400
2023-12-31GSA Capital Partners LLP0.31840.023548849620555972.6519
2023-12-31State Street Corporation0.3041046654500
2023-12-31Morgan Stanley - Brokerage Accounts0.24130370218-40881-9.9443
2023-12-31Northern Trust Corp0.217803341356844125.7593
2023-12-31Cubist Systematic Strategies, LLC0.18090.00127756333951.2383
2023-12-31IHT Wealth Management, LLC0.15490.0061237568-18382-7.1819
2023-12-31Raymond James Finl Svs Advisors, Inc.0.12750.0002195619-13836-6.6057
2023-12-31Millennium Management LLC0.11670178976-1402962-88.6863
2023-12-31Bank of America Corp0.11470176009-11906-6.3358
2023-12-31Charles Schwab Investment Management Inc0.10010153547-161274-51.2272
2023-12-31Private Portfolio Partners LLC0.06730.0136103170-8500-7.6117
2023-12-31Group One Trading, LP0.05390.0001827611000.121
2023-12-31Dimensional Fund Advisors, Inc.0.0516079100-11995-13.1676
2023-12-31T. Rowe Price Associates, Inc.0.051207850000
2023-12-31Susquehanna International Group, LLP0.0509078139-30761-28.247
2023-12-31Hbk Sorce Advisory LLC0.0490.00177511800
2023-12-31AE Wealth Management LLC0.04050.000362166530.0853
Total 9.27860.046714234098-1159420-8.1%

3.2. Funds holding Vaxart Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv2.65260.0003406932800
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.22060.0023187250600
2024-01-31Fidelity Extended Market Index0.54820.002884097100
2024-01-31Vanguard Health Care ETF0.34480.003152896636300.691
2023-09-30BlackRock Extended Mkt Composite0.24150.00237053000
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.2360.013936197300
2023-12-31BlackRock Extended Equity Market K0.21070.0013323257-651-0.201
2024-02-29Fidelity Nasdaq Composite ETF0.20670.0065317105-672-0.2115
2024-01-31Fidelity Total Market Index0.1540.000323620600
2024-01-31Fidelity Series Total Market Index0.12810.000419652700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.11850.00171817466941661.7965
2024-01-31Fidelity Nasdaq Composite Index0.10920.001416752800
2024-01-31Schwab Total Stock Market Index0.10010.000915354700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.09510.00171459685592062.1002
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0920.001414114100
2023-12-31Northern Trust Extended Eq Market Idx0.0920.001414114100
2024-01-31A4Investments SICAV SIF ACCI IlanaA2EURH0.06971.14521068581068580
2024-01-31Spartan Total Market Index Pool E0.05980.00049173900
2024-01-31Vanguard Balanced Index Inv0.05760.00028830000
2024-01-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.05350.00038206300
Total 6.79071.187510417400+234501+2.3%

3.3. Insider Transactions

Insiders are holding 0.719% of the shares of Vaxart Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-28W. Mark WatsonBUY200000.76
2022-06-22Fuad AhmadBUY50003.22
2022-01-10Robert A YedidSELL15006.01
2021-11-30Margaret EcherdSELL36028
2021-09-10Margaret EcherdSELL18019.1
2021-08-10Sean TuckerSELL417210.2
2021-07-19Margaret EcherdSELL18008
2021-06-09Margaret EcherdSELL475558
2021-05-07Wouter LatourSELL1000007.13

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vaxart Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.079-0.076-4%-0.111+40%0.013-689%-0.001-99%
Book Value Per Share--0.3320.437-24%0.780-57%0.576-42%0.408-18%
Current Ratio--3.3184.588-28%8.428-61%7.691-57%7.037-53%
Debt To Asset Ratio--0.3710.327+13%0.241+54%0.320+16%0.343+8%
Debt To Equity Ratio--0.5890.489+20%0.324+82%0.598-2%0.689-15%
Dividend Per Share----0%-0%-0%-0%
Eps---0.100-0.119+19%-0.155+55%-0.090-10%-0.059-41%
Free Cash Flow Per Share---0.077-0.104+35%-0.157+104%-0.082+6%-0.049-36%
Free Cash Flow To Equity Per Share---0.078-0.082+6%-0.132+71%0.008-1094%0.006-1477%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.271--------
Intrinsic Value_10Y_min---4.656--------
Intrinsic Value_1Y_max---0.202--------
Intrinsic Value_1Y_min---0.475--------
Intrinsic Value_3Y_max---0.627--------
Intrinsic Value_3Y_min---1.428--------
Intrinsic Value_5Y_max---1.075--------
Intrinsic Value_5Y_min---2.376--------
Market Cap226020600.000+56%99588153.600122290184.250-19%507716158.950-80%595946777.400-83%1207915538360.722-100%
Net Profit Margin---2.623-23.871+810%-345.622+13078%-109.443+4073%-61.985+2263%
Operating Margin----22.9620%-292.3930%-95.4470%-54.8840%
Operating Ratio--3.55133.752-89%378.871-99%120.792-97%103.777-97%
Pb Ratio3.910+56%1.7231.628+6%3.532-51%7.638-77%26144.130-100%
Pe Ratio-3.252-127%-1.433-1.508+5%-4.719+229%-16.181+1029%-42520.222+2967276%
Price Per Share1.300+56%0.5730.703-19%2.920-80%3.428-83%2.750-79%
Price To Free Cash Flow Ratio-4.211-127%-1.856-1.763-5%-4.826+160%-49.366+2560%301865.726-100%
Price To Total Gains Ratio-16.479-127%-7.261-12.591+73%-25.012+244%25.459-129%-21.344+194%
Quick Ratio--0.5804.941-88%10.693-95%8.419-93%8.032-93%
Return On Assets---0.189-0.183-3%-0.153-19%-0.122-35%-0.110-42%
Return On Equity---0.301-0.272-9%-0.203-32%-0.197-34%-0.196-35%
Total Gains Per Share---0.079-0.076-4%-0.111+40%0.013-689%-0.001-99%
Usd Book Value--57805000.00076038000.000-24%135590750.000-57%100094850.000-42%72021512.195-20%
Usd Book Value Change Per Share---0.079-0.076-4%-0.111+40%0.013-689%-0.001-99%
Usd Book Value Per Share--0.3320.437-24%0.780-57%0.576-42%0.408-18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.100-0.119+19%-0.155+55%-0.090-10%-0.059-41%
Usd Free Cash Flow---13417000.000-18081000.000+35%-27354500.000+104%-14282200.000+6%-8573146.341-36%
Usd Free Cash Flow Per Share---0.077-0.104+35%-0.157+104%-0.082+6%-0.049-36%
Usd Free Cash Flow To Equity Per Share---0.078-0.082+6%-0.132+71%0.008-1094%0.006-1477%
Usd Market Cap226020600.000+56%99588153.600122290184.250-19%507716158.950-80%595946777.400-83%1207915538360.722-100%
Usd Price Per Share1.300+56%0.5730.703-19%2.920-80%3.428-83%2.750-79%
Usd Profit---17375000.000-20616250.000+19%-26939500.000+55%-15577900.000-10%-10365000.000-40%
Usd Revenue--6625000.0002276000.000+191%26750.000+24666%1200550.000+452%2723658.537+143%
Usd Total Gains Per Share---0.079-0.076-4%-0.111+40%0.013-689%-0.001-99%
 EOD+5 -3MRQTTM+14 -18YOY+18 -145Y+9 -2310Y+8 -24

4.2. Fundamental Score

Let's check the fundamental score of Vaxart Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.252
Price to Book Ratio (EOD)Between0-13.910
Net Profit Margin (MRQ)Greater than0-2.623
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.580
Current Ratio (MRQ)Greater than13.318
Debt to Asset Ratio (MRQ)Less than10.371
Debt to Equity Ratio (MRQ)Less than10.589
Return on Equity (MRQ)Greater than0.15-0.301
Return on Assets (MRQ)Greater than0.05-0.189
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Vaxart Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.562
Ma 20Greater thanMa 501.194
Ma 50Greater thanMa 1001.143
Ma 100Greater thanMa 2000.910
OpenGreater thanClose1.330
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  28018446459523-7516-814-298



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets91,830
Total Liabilities34,025
Total Stockholder Equity57,805
 As reported
Total Liabilities 34,025
Total Stockholder Equity+ 57,805
Total Assets = 91,830

Assets

Total Assets91,830
Total Current Assets45,536
Long-term Assets46,294
Total Current Assets
Cash And Cash Equivalents 34,755
Short-term Investments 4,958
Net Receivables 3,008
Other Current Assets 2,815
Total Current Assets  (as reported)45,536
Total Current Assets  (calculated)45,536
+/-0
Long-term Assets
Property Plant Equipment 36,571
Goodwill 4,508
Intangible Assets 4,289
Long-term Assets Other 926
Long-term Assets  (as reported)46,294
Long-term Assets  (calculated)46,294
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,724
Long-term Liabilities20,301
Total Stockholder Equity57,805
Total Current Liabilities
Accounts payable 1,584
Other Current Liabilities 3,803
Total Current Liabilities  (as reported)13,724
Total Current Liabilities  (calculated)5,387
+/- 8,337
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt20,088
Long-term Liabilities  (as reported)20,301
Long-term Liabilities  (calculated)20,088
+/- 213
Total Stockholder Equity
Total Stockholder Equity (as reported)57,805
Total Stockholder Equity (calculated)0
+/- 57,805
Other
Capital Stock15
Common Stock Shares Outstanding 153,409
Net Invested Capital 57,805
Net Working Capital 31,812
Property Plant and Equipment Gross 43,402



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-05-022017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-311986-12-311986-09-301986-06-301986-03-311985-12-311985-09-30
> Total Assets 
0
10,000
0
0
0
13,400
0
0
0
13,600
0
0
0
20,900
0
21,200
23,000
24,400
23,900
24,100
26,000
23,700
22,200
22,000
27,000
26,600
40,700
42,200
47,400
47,500
47,100
49,700
52,900
52,900
73,500
78,200
82,500
93,800
96,700
106,400
119,100
138,000
138,000
186,600
191,100
202,100
207,200
212,400
223,600
225,900
224,400
215,800
212,400
218,300
209,600
202,200
203,100
214,600
204,075
214,418
213,795
224,487
215,865
219,781
298,398
310,309
295,123
221,416
222,207
232,816
225,987
230,510
307,027
387,301
382,605
389,964
378,090
368,171
330,354
432,215
415,018
329,336
302,944
288,833
277,658
265,877
239,148
232,430
223,854
238,570
214,543
175,748
167,580
144,221
137,103
118,167
112,175
131,317
163,041
125,291
120,476
113,871
110,947
105,339
104,051
97,965
95,236
92,950
66,510
96,182
94,839
85,800
79,000
82,700
120,500
114,000
97,300
93,400
88,800
79,400
71,000
64,200
61,900
72,700
63,100
56,500
46,700
46,000
40,100
34,700
32,600
56,537
47,759
40,636
35,227
36,309
37,250
42,695
37,032
52,564
64,190
154,710
152,582
205,866
228,844
241,136
221,168
200,378
181,454
175,309
153,847
129,851
122,653
105,642
91,830
91,830105,642122,653129,851153,847175,309181,454200,378221,168241,136228,844205,866152,582154,71064,19052,56437,03242,69537,25036,30935,22740,63647,75956,53732,60034,70040,10046,00046,70056,50063,10072,70061,90064,20071,00079,40088,80093,40097,300114,000120,50082,70079,00085,80094,83996,18266,51092,95095,23697,965104,051105,339110,947113,871120,476125,291163,041131,317112,175118,167137,103144,221167,580175,748214,543238,570223,854232,430239,148265,877277,658288,833302,944329,336415,018432,215330,354368,171378,090389,964382,605387,301307,027230,510225,987232,816222,207221,416295,123310,309298,398219,781215,865224,487213,795214,418204,075214,600203,100202,200209,600218,300212,400215,800224,400225,900223,600212,400207,200202,100191,100186,600138,000138,000119,100106,40096,70093,80082,50078,20073,50052,90052,90049,70047,10047,50047,40042,20040,70026,60027,00022,00022,20023,70026,00024,10023,90024,40023,00021,200020,90000013,60000013,40000010,0000
   > Total Current Assets 
0
7,100
0
0
0
9,200
0
0
0
9,200
0
0
0
9,900
0
16,200
17,900
16,100
15,900
16,100
18,300
16,300
15,000
14,700
19,900
20,100
20,000
19,600
20,500
20,900
20,800
23,400
26,800
26,500
32,000
36,400
39,600
48,100
47,800
51,100
52,000
57,200
57,200
98,400
98,900
98,100
95,900
89,400
100,200
99,000
95,500
85,500
79,900
85,500
79,200
69,700
70,000
78,906
66,830
74,007
71,166
77,876
67,840
69,962
178,926
193,063
179,302
105,058
105,473
113,046
106,065
110,655
93,245
186,585
183,699
192,031
174,462
162,588
126,679
231,028
212,931
232,602
133,611
123,373
184,976
175,164
150,291
144,844
138,034
226,193
202,367
173,867
165,888
142,177
135,147
116,701
110,833
129,693
161,569
109,700
111,491
110,026
107,864
104,923
103,777
97,881
95,219
92,950
66,510
87,989
87,285
80,000
75,000
79,300
117,500
101,100
76,100
86,200
87,400
70,800
61,200
58,600
60,500
72,400
62,800
56,200
46,400
46,000
39,900
34,500
32,400
31,896
25,503
19,167
14,645
15,250
17,107
21,254
17,598
33,665
45,726
135,591
128,531
175,420
189,492
192,300
169,167
154,180
137,810
120,380
99,451
75,830
71,261
57,100
45,536
45,53657,10071,26175,83099,451120,380137,810154,180169,167192,300189,492175,420128,531135,59145,72633,66517,59821,25417,10715,25014,64519,16725,50331,89632,40034,50039,90046,00046,40056,20062,80072,40060,50058,60061,20070,80087,40086,20076,100101,100117,50079,30075,00080,00087,28587,98966,51092,95095,21997,881103,777104,923107,864110,026111,491109,700161,569129,693110,833116,701135,147142,177165,888173,867202,367226,193138,034144,844150,291175,164184,976123,373133,611232,602212,931231,028126,679162,588174,462192,031183,699186,58593,245110,655106,065113,046105,473105,058179,302193,063178,92669,96267,84077,87671,16674,00766,83078,90670,00069,70079,20085,50079,90085,50095,50099,000100,20089,40095,90098,10098,90098,40057,20057,20052,00051,10047,80048,10039,60036,40032,00026,50026,80023,40020,80020,90020,50019,60020,00020,10019,90014,70015,00016,30018,30016,10015,90016,10017,90016,20009,9000009,2000009,2000007,1000
       Cash And Cash Equivalents 
0
1,500
0
0
0
400
0
0
0
200
0
0
0
300
0
200
400
600
300
700
400
600
300
400
4,000
300
3,100
400
600
1,000
600
600
1,300
800
900
1,400
1,300
2,000
1,800
1,900
2,400
4,000
4,000
6,300
14,800
18,500
20,300
5,400
8,000
3,400
1,200
1,800
700
1,000
2,000
1,100
600
806
2,874
1,586
1,539
1,554
2,270
1,954
131,034
131,192
126,117
46,708
43,540
51,737
46,939
58,611
26,248
115,756
116,779
117,002
110,780
94,759
49,813
94,346
55,262
101,762
51,396
31,121
32,020
86,227
84,663
68,517
78,040
217,606
197,724
160,550
152,249
106,438
114,190
107,658
28,148
59,510
147,707
32,454
37,280
53,564
59,092
86,618
92,948
94,310
94,875
92,649
66,322
74,111
70,265
66,800
60,800
51,400
80,100
81,700
57,700
63,700
61,500
44,700
45,300
39,000
30,600
49,700
45,900
38,100
11,800
11,000
17,700
19,600
29,400
17,495
23,921
17,922
11,456
8,374
16,258
19,558
13,526
29,859
44,388
133,438
126,870
157,311
165,266
167,231
143,745
123,404
91,468
50,768
44,013
48,434
43,277
32,448
34,755
34,75532,44843,27748,43444,01350,76891,468123,404143,745167,231165,266157,311126,870133,43844,38829,85913,52619,55816,2588,37411,45617,92223,92117,49529,40019,60017,70011,00011,80038,10045,90049,70030,60039,00045,30044,70061,50063,70057,70081,70080,10051,40060,80066,80070,26574,11166,32292,64994,87594,31092,94886,61859,09253,56437,28032,454147,70759,51028,148107,658114,190106,438152,249160,550197,724217,60678,04068,51784,66386,22732,02031,12151,396101,76255,26294,34649,81394,759110,780117,002116,779115,75626,24858,61146,93951,73743,54046,708126,117131,192131,0341,9542,2701,5541,5391,5862,8748066001,1002,0001,0007001,8001,2003,4008,0005,40020,30018,50014,8006,3004,0004,0002,4001,9001,8002,0001,3001,4009008001,3006006001,0006004003,1003004,00040030060040070030060040020003000002000004000001,5000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,350
20,900
62,525
81,250
5,172
30,222
39,097
32,925
32,500
26,500
35,425
21,725
1,600
0
0
0
23,900
9,135
1,034
75,145
59,489
10,382
71,206
66,953
54,603
41,433
15,706
9,065
2,079
2,079
0
0
0
0
0
0
0
0
0
1,100
7,100
12,000
12,900
11,900
13,000
18,400
19,300
12,400
11,100
25,800
25,000
20,900
14,500
1,415
0
0
0
0
0
0
0
0
0
0
0
0
13,385
19,318
20,438
22,742
24,254
38,078
63,999
49,704
23,377
24,628
19,799
4,958
4,95819,79924,62823,37749,70463,99938,07824,25422,74220,43819,31813,3850000000000001,41514,50020,90025,00025,80011,10012,40019,30018,40013,00011,90012,90012,0007,1001,1000000000002,0792,0799,06515,70641,43354,60366,95371,20610,38259,48975,1451,0349,13523,9000001,60021,72535,42526,50032,50032,92539,09730,2225,17281,25062,52520,9008,35000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
2,500
0
0
0
3,100
0
0
0
3,500
0
0
0
2,800
0
3,400
9,900
4,800
5,400
5,800
5,600
5,300
5,500
4,600
5,700
8,000
6,700
7,800
8,600
7,900
8,400
8,900
11,900
13,000
14,400
15,800
17,500
22,900
22,600
26,000
24,700
28,200
28,200
48,500
40,900
38,100
37,500
37,800
33,900
36,100
35,100
33,600
32,100
40,000
33,700
31,900
28,100
34,019
22,763
32,109
31,076
38,315
30,262
34,435
23,413
36,039
26,870
34,215
34,942
36,326
29,440
22,466
35,954
37,062
36,904
45,045
34,706
32,405
20,442
29,310
15,784
19,683
25,891
25,570
11,223
20,377
17,200
16,489
14,313
2,371
0
0
0
0
0
0
0
9,122
2,181
4,585
3,988
1,030
6,479
726
891
995
128
0
0
11,383
15,173
11,000
12,900
26,900
36,500
18,700
16,800
14,400
13,000
12,600
3,200
5,100
10,100
700
600
4,200
6,600
600
600
100
2,500
13,349
561
256
1,796
5,584
35
559
3,619
2,663
227
250
334
700
107
190
71
81
5,478
1,923
20
264
29
424
3,008
3,00842429264201,9235,47881711901077003342502272,6633,619559355,5841,79625656113,3492,5001006006006,6004,20060070010,1005,1003,20012,60013,00014,40016,80018,70036,50026,90012,90011,00015,17311,383001289958917266,4791,0303,9884,5852,1819,12200000002,37114,31316,48917,20020,37711,22325,57025,89119,68315,78429,31020,44232,40534,70645,04536,90437,06235,95422,46629,44036,32634,94234,21526,87036,03923,41334,43530,26238,31531,07632,10922,76334,01928,10031,90033,70040,00032,10033,60035,10036,10033,90037,80037,50038,10040,90048,50028,20028,20024,70026,00022,60022,90017,50015,80014,40013,00011,9008,9008,4007,9008,6007,8006,7008,0005,7004,6005,5005,3005,6005,8005,4004,8009,9003,40002,8000003,5000003,1000002,5000
       Other Current Assets 
0
200
0
0
0
400
0
0
0
200
0
0
0
900
0
6,600
900
3,700
2,100
2,100
2,400
2,100
2,400
2,400
2,400
3,400
1,700
2,000
2,100
2,400
2,400
2,700
2,500
1,900
1,900
3,500
2,600
2,500
3,100
3,000
2,800
2,400
2,400
19,900
17,200
13,100
3,800
4,100
9,400
16,100
18,700
13,500
7,900
6,300
7,100
3,700
6,000
8,149
6,528
6,887
5,521
5,405
5,410
3,312
8,561
7,694
5,774
3,906
5,312
5,595
6,560
5,272
5,224
10,284
8,854
7,658
7,481
6,899
13,552
-1
33,365
81,220
3,905
4,441
82,190
13,341
309
338
227
4,616
2,381
1,425
13,639
246
10,358
5,888
5,677
4,004
1,299
1,455
3,270
829
860
1,873
873
497
216
301
188
2,495
1,847
2,200
1,300
1,000
900
700
500
1,000
900
600
800
1,500
1,400
2,700
3,900
2,800
2,200
700
700
300
500
1,052
1,021
989
1,343
1,292
814
1,137
453
1,143
1,111
1,903
1,327
4,024
4,801
4,441
2,609
6,441
8,264
5,613
3,714
3,755
3,327
3,639
2,815
2,8153,6393,3273,7553,7145,6138,2646,4412,6094,4414,8014,0241,3271,9031,1111,1434531,1378141,2921,3439891,0211,0525003007007002,2002,8003,9002,7001,4001,5008006009001,0005007009001,0001,3002,2001,8472,4951883012164978731,8738608293,2701,4551,2994,0045,6775,88810,35824613,6391,4252,3814,61622733830913,34182,1904,4413,90581,22033,365-113,5526,8997,4817,6588,85410,2845,2245,2726,5605,5955,3123,9065,7747,6948,5613,3125,4105,4055,5216,8876,5288,1496,0003,7007,1006,3007,90013,50018,70016,1009,4004,1003,80013,10017,20019,9002,4002,4002,8003,0003,1002,5002,6003,5001,9001,9002,5002,7002,4002,4002,1002,0001,7003,4002,4002,4002,4002,1002,4002,1002,1003,7009006,60009000002000004000002000
   > Long-term Assets 
0
2,900
0
0
0
4,200
0
0
0
4,400
0
0
0
11,000
0
5,000
5,100
8,300
8,000
8,000
7,700
7,400
7,200
7,300
7,100
6,500
20,700
22,600
26,900
26,600
26,300
26,300
26,100
26,400
41,500
41,800
42,900
45,700
48,900
55,300
67,100
80,800
80,800
88,200
92,200
104,000
111,300
123,000
123,400
126,900
128,900
130,300
132,500
132,800
130,400
132,500
133,100
135,694
137,245
140,411
142,629
146,611
148,025
149,819
119,472
117,246
115,821
116,358
116,734
119,770
119,922
119,855
213,782
200,716
198,906
197,933
203,628
205,583
203,675
201,187
202,087
96,734
169,333
165,460
92,682
90,713
88,857
87,586
85,820
12,377
12,176
1,881
1,692
2,044
1,956
1,466
1,342
1,624
1,472
15,591
8,985
3,845
3,083
416
274
84
17
0
0
8,193
7,554
5,800
4,000
3,400
3,000
12,900
21,200
7,200
1,400
8,600
9,800
5,600
1,400
300
300
300
300
200
200
200
200
24,641
22,256
21,469
20,582
21,059
20,143
21,441
19,434
18,899
18,464
19,119
24,051
30,446
39,352
48,836
52,001
46,198
43,644
54,929
54,396
54,021
51,392
48,542
46,294
46,29448,54251,39254,02154,39654,92943,64446,19852,00148,83639,35230,44624,05119,11918,46418,89919,43421,44120,14321,05920,58221,46922,25624,6412002002002003003003003001,4005,6009,8008,6001,4007,20021,20012,9003,0003,4004,0005,8007,5548,1930017842744163,0833,8458,98515,5911,4721,6241,3421,4661,9562,0441,6921,88112,17612,37785,82087,58688,85790,71392,682165,460169,33396,734202,087201,187203,675205,583203,628197,933198,906200,716213,782119,855119,922119,770116,734116,358115,821117,246119,472149,819148,025146,611142,629140,411137,245135,694133,100132,500130,400132,800132,500130,300128,900126,900123,400123,000111,300104,00092,20088,20080,80080,80067,10055,30048,90045,70042,90041,80041,50026,40026,10026,30026,30026,60026,90022,60020,7006,5007,1007,3007,2007,4007,7008,0008,0008,3005,1005,000011,0000004,4000004,2000002,9000
       Property Plant Equipment 
0
1,700
0
0
0
2,800
0
0
0
2,900
0
0
0
3,500
0
3,600
3,900
4,000
4,000
4,100
4,100
4,400
4,400
4,600
4,900
4,900
5,000
5,800
6,000
6,100
6,100
6,200
6,400
6,600
9,100
9,900
10,700
14,200
17,600
24,400
31,700
42,700
42,700
49,900
53,800
60,600
66,700
77,900
82,300
89,200
91,900
94,100
97,200
99,000
97,700
102,200
105,800
109,100
111,081
114,810
117,510
120,188
122,105
124,243
109,314
107,866
106,709
106,399
105,093
103,706
101,730
100,089
100,444
101,831
100,874
102,690
110,174
115,406
115,573
115,041
114,595
93,865
92,280
90,564
90,174
88,329
86,566
84,816
83,083
1,971
1,717
1,568
1,404
1,315
1,200
1,083
966
855
745
601
520
597
339
295
274
84
17
0
0
4,454
4,173
4,300
3,500
3,100
2,800
2,000
1,600
1,100
300
200
200
400
400
300
300
300
300
200
200
200
200
1,014
1,034
1,059
1,066
2,321
2,082
3,770
2,200
2,101
2,100
3,253
8,318
8,595
10,147
17,664
19,769
20,499
21,769
38,887
41,300
42,216
40,718
38,679
36,571
36,57138,67940,71842,21641,30038,88721,76920,49919,76917,66410,1478,5958,3183,2532,1002,1012,2003,7702,0822,3211,0661,0591,0341,0142002002002003003003003004004002002003001,1001,6002,0002,8003,1003,5004,3004,1734,4540017842742953395975206017458559661,0831,2001,3151,4041,5681,7171,97183,08384,81686,56688,32990,17490,56492,28093,865114,595115,041115,573115,406110,174102,690100,874101,831100,444100,089101,730103,706105,093106,399106,709107,866109,314124,243122,105120,188117,510114,810111,081109,100105,800102,20097,70099,00097,20094,10091,90089,20082,30077,90066,70060,60053,80049,90042,70042,70031,70024,40017,60014,20010,7009,9009,1006,6006,4006,2006,1006,1006,0005,8005,0004,9004,9004,6004,4004,4004,1004,1004,0004,0003,9003,60003,5000002,9000002,8000001,7000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,100
12,900
0
12,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,508
4,508
4,508
4,508
4,508
4,508
4,508
4,508
4,508
4,5084,5084,5084,5084,5084,5084,5084,5084,50800000000000000000000000000000000000000000000000000000000000000000000000000000000000012,500012,90013,1000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
18,800
0
0
7,900
0
5,200
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,554
14,339
16,282
16,210
9,349
1,940
63,999
0
0
0
0
0
0000063,9991,9409,34916,21016,28214,3396,554000000000000000000001,0005,20007,9000018,80010,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
800
0
0
0
800
0
0
0
700
0
0
0
600
0
500
500
0
0
0
0
0
0
0
0
0
13,900
14,900
18,900
18,500
18,200
17,900
17,600
17,300
29,700
29,000
28,400
27,300
26,800
26,300
30,300
29,900
29,900
28,900
28,100
27,800
27,100
26,600
26,200
25,200
24,700
24,200
23,700
23,200
22,400
20,000
19,600
19,200
18,884
18,504
18,149
19,600
19,223
19,041
4,059
6,859
7,115
7,994
9,718
13,050
15,178
15,756
109,390
94,991
94,292
93,313
91,975
89,728
87,606
85,433
83,210
1,955
76,201
74,070
1,751
1,683
1,615
1,247
1,216
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,312
818
600
500
300
200
0
0
0
0
0
0
48
0
0
0
44
0
0
0
0
40
23,627
21,222
20,410
19,413
18,634
17,959
17,526
17,093
16,660
16,227
15,794
15,361
14,928
14,495
14,062
10,624
10,286
9,949
9,611
5,020
4,837
4,654
4,472
4,289
4,2894,4724,6544,8375,0209,6119,94910,28610,62414,06214,49514,92815,36115,79416,22716,66017,09317,52617,95918,63419,41320,41021,22223,62740000044000480000002003005006008181,312000000000000000000001,2161,2471,6151,6831,75174,07076,2011,95583,21085,43387,60689,72891,97593,31394,29294,991109,39015,75615,17813,0509,7187,9947,1156,8594,05919,04119,22319,60018,14918,50418,88419,20019,60020,00022,40023,20023,70024,20024,70025,20026,20026,60027,10027,80028,10028,90029,90029,90030,30026,30026,80027,30028,40029,00029,70017,30017,60017,90018,20018,50018,90014,90013,90000000000050050006000007000008000008000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,627
21,222
20,410
103
104
102
145
141
138
137
72
372
369
371
828
890
1,556
5,478
1,923
3,568
0
1,508
0
0
001,50803,5681,9235,4781,5568908283713693727213713814114510210410320,41021,22223,62700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,427
2,563
0
0
0
0
900
800
0
0
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000005000080090000002,5632,4270000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
7,300
0
0
0
7,300
0
0
0
5,600
0
0
0
12,600
0
12,400
13,700
14,700
13,600
13,300
14,500
11,600
9,200
8,300
12,900
11,500
30,100
30,800
33,200
33,600
32,400
34,200
36,400
34,900
45,900
47,800
50,000
42,000
41,900
48,100
57,400
68,600
68,600
113,200
116,300
116,000
119,800
123,000
142,100
150,200
150,600
142,500
142,600
164,100
156,100
147,700
147,000
156,400
142,156
149,446
139,647
147,093
137,730
139,445
116,178
123,103
108,978
33,958
33,900
43,787
36,143
43,100
75,960
67,985
65,242
80,568
78,241
83,850
60,635
181,499
178,729
167,509
158,553
157,515
164,579
154,489
138,181
134,798
140,704
92,038
89,824
50,401
43,350
22,839
22,492
12,013
12,547
33,910
68,748
60,665
55,814
53,301
47,529
45,643
43,364
39,094
35,826
35,615
36,543
17,220
14,735
17,800
14,100
18,500
24,500
27,100
19,400
11,000
7,300
9,900
7,500
6,700
9,200
26,500
26,500
28,500
22,500
22,000
21,400
20,800
21,800
25,431
25,406
24,648
23,989
23,733
21,405
23,792
24,080
21,271
23,955
23,032
29,178
29,631
29,062
36,188
33,637
34,013
38,360
53,002
43,250
40,098
37,580
34,121
34,025
34,02534,12137,58040,09843,25053,00238,36034,01333,63736,18829,06229,63129,17823,03223,95521,27124,08023,79221,40523,73323,98924,64825,40625,43121,80020,80021,40022,00022,50028,50026,50026,5009,2006,7007,5009,9007,30011,00019,40027,10024,50018,50014,10017,80014,73517,22036,54335,61535,82639,09443,36445,64347,52953,30155,81460,66568,74833,91012,54712,01322,49222,83943,35050,40189,82492,038140,704134,798138,181154,489164,579157,515158,553167,509178,729181,49960,63583,85078,24180,56865,24267,98575,96043,10036,14343,78733,90033,958108,978123,103116,178139,445137,730147,093139,647149,446142,156156,400147,000147,700156,100164,100142,600142,500150,600150,200142,100123,000119,800116,000116,300113,20068,60068,60057,40048,10041,90042,00050,00047,80045,90034,90036,40034,20032,40033,60033,20030,80030,10011,50012,9008,3009,20011,60014,50013,30013,60014,70013,70012,400012,6000005,6000007,3000007,3000
   > Total Current Liabilities 
0
5,300
0
0
0
6,200
0
0
0
5,400
0
0
0
5,000
0
9,400
9,900
9,500
8,600
6,900
7,700
10,800
8,400
7,700
12,200
7,100
7,700
7,800
26,800
11,200
10,800
11,900
20,400
13,900
18,400
21,500
22,800
22,500
23,800
21,100
22,400
42,500
42,500
31,700
35,000
34,500
28,300
27,800
27,400
35,000
33,300
34,000
32,700
45,800
46,600
42,200
45,500
42,907
28,958
34,557
29,770
38,282
30,098
37,226
37,467
44,413
108,812
33,540
33,506
38,551
30,931
27,187
37,784
39,056
44,334
56,385
58,015
64,406
49,132
59,559
52,919
47,041
48,827
47,888
54,951
44,938
27,997
25,158
31,018
20,300
18,058
9,412
9,171
7,637
7,069
6,238
6,685
33,910
31,485
24,034
19,814
17,933
12,792
11,537
9,890
6,252
3,615
4,036
5,595
16,945
14,439
17,600
13,800
18,300
24,300
26,900
19,300
10,900
7,200
9,000
6,700
6,000
8,700
9,200
8,800
10,500
5,500
5,000
5,900
5,200
5,700
7,801
8,794
8,026
7,475
8,550
7,477
9,154
9,174
7,441
11,498
10,302
11,763
11,642
12,780
12,595
10,783
11,035
15,926
21,740
17,921
15,683
13,883
11,268
13,724
13,72411,26813,88315,68317,92121,74015,92611,03510,78312,59512,78011,64211,76310,30211,4987,4419,1749,1547,4778,5507,4758,0268,7947,8015,7005,2005,9005,0005,50010,5008,8009,2008,7006,0006,7009,0007,20010,90019,30026,90024,30018,30013,80017,60014,43916,9455,5954,0363,6156,2529,89011,53712,79217,93319,81424,03431,48533,9106,6856,2387,0697,6379,1719,41218,05820,30031,01825,15827,99744,93854,95147,88848,82747,04152,91959,55949,13264,40658,01556,38544,33439,05637,78427,18730,93138,55133,50633,540108,81244,41337,46737,22630,09838,28229,77034,55728,95842,90745,50042,20046,60045,80032,70034,00033,30035,00027,40027,80028,30034,50035,00031,70042,50042,50022,40021,10023,80022,50022,80021,50018,40013,90020,40011,90010,80011,20026,8007,8007,7007,10012,2007,7008,40010,8007,7006,9008,6009,5009,9009,40005,0000005,4000006,2000005,3000
       Short-term Debt 
0
1,400
0
0
0
2,100
0
0
0
1,100
0
0
0
800
0
4,700
4,400
2,400
800
1,000
900
6,700
5,600
4,900
9,500
2,700
2,500
2,700
20,100
2,300
2,900
2,700
11,800
3,000
6,000
6,700
8,200
5,500
7,500
6,500
7,600
17,200
17,200
5,400
5,400
2,200
4,500
6,000
6,400
6,300
2,200
5,800
5,400
100
5,200
5,300
5,100
704
917
1,000
1,000
1,000
1,000
1,000
0
0
78,500
0
0
0
0
1,500
6,014
4,226
8,233
8,280
10,107
10,173
8,862
7,316
5,238
223
10,404
10,549
223
291
229
155
67
0
0
0
0
0
0
0
0
5,951
6,042
5,409
6,667
7,377
5,061
5,615
4,564
1,918
0
0
0
0
0
0
0
0
0
-700
0
0
0
200
200
400
500
400
400
300
300
300
200
200
300
1,881
1,820
1,769
1,667
2,364
2,232
3,274
841
855
804
1,699
2,052
2,006
1,791
1,345
1,011
1,079
1,110
2,149
2,228
2,344
2,430
2,517
0
02,5172,4302,3442,2282,1491,1101,0791,0111,3451,7912,0062,0521,6998048558413,2742,2322,3641,6671,7691,8201,881300200200300300300400400500400200200000-7000000000001,9184,5645,6155,0617,3776,6675,4096,0425,951000000006715522929122310,54910,4042235,2387,3168,86210,17310,1078,2808,2334,2266,0141,500000078,500001,0001,0001,0001,0001,0009177045,1005,3005,2001005,4005,8002,2006,3006,4006,0004,5002,2005,4005,40017,20017,2007,6006,5007,5005,5008,2006,7006,0003,00011,8002,7002,9002,30020,1002,7002,5002,7009,5004,9005,6006,7009001,0008002,4004,4004,70008000001,1000002,1000001,4000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200
0
18,947
0
400
0
37,549
37,549
0
200
200
1,528
1,667
1,667
1,667
1,667
1,667
1,667
2,454
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,4541,6671,6671,6671,6671,6671,6671,528200200037,54937,5490400018,94701,20000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,100
3,700
5,500
5,700
3,800
3,900
2,700
2,000
1,900
1,600
2,700
2,200
2,900
3,100
4,300
3,400
4,500
4,300
4,700
5,500
4,500
4,800
6,600
6,100
3,900
4,700
9,400
9,400
5,900
5,400
9,800
8,000
6,900
7,200
11,400
12,400
10,000
9,500
15,000
17,300
12,700
17,600
16,025
12,037
13,701
14,425
15,923
13,921
12,921
11,450
20,654
18,869
18,612
15,010
21,654
15,022
7,939
7,826
10,874
14,298
16,429
18,480
21,943
15,509
16,529
18,057
12,377
10,994
10,876
10,039
7,998
7,450
6,751
7,323
3,647
2,637
1,048
1,097
1,226
1,486
1,333
1,505
1,735
2,436
3,350
508
552
362
1,189
983
146
69
75
333
4,466
2,282
2,400
2,100
9,600
7,300
2,800
1,400
1,700
1,000
1,900
2,900
1,300
3,700
3,900
1,600
3,400
1,800
4,300
1,400
1,300
1,700
1,744
1,449
1,301
962
849
610
1,049
852
793
1,166
1,871
2,133
4,638
3,702
3,745
3,872
4,017
5,007
7,916
5,514
3,882
4,199
1,339
1,584
1,5841,3394,1993,8825,5147,9165,0074,0173,8723,7453,7024,6382,1331,8711,1667938521,0496108499621,3011,4491,7441,7001,3001,4004,3001,8003,4001,6003,9003,7001,3002,9001,9001,0001,7001,4002,8007,3009,6002,1002,4002,2824,46633375691469831,1893625525083,3502,4361,7351,5051,3331,4861,2261,0971,0482,6373,6477,3236,7517,4507,99810,03910,87610,99412,37718,05716,52915,50921,94318,48016,42914,29810,8747,8267,93915,02221,65415,01018,61218,86920,65411,45012,92113,92115,92314,42513,70112,03716,02517,60012,70017,30015,0009,50010,00012,40011,4007,2006,9008,0009,8005,4005,9009,4009,4004,7003,9006,1006,6004,8004,5005,5004,7004,3004,5003,4004,3003,1002,9002,2002,7001,6001,9002,0002,7003,9003,8005,7005,5003,7003,100000000000000000
       Other Current Liabilities 
0
3,900
0
0
0
4,100
0
0
0
4,300
0
0
0
4,200
0
1,600
1,800
1,600
2,100
2,100
2,900
1,400
800
900
1,100
1,700
3,000
2,200
3,600
4,600
4,500
4,700
4,300
6,200
6,900
10,300
9,800
10,400
10,200
10,700
10,100
15,900
15,900
20,400
24,200
22,500
15,800
14,900
13,800
17,300
18,700
18,200
17,800
30,700
24,100
24,200
22,800
26,178
16,004
19,856
14,345
21,359
15,177
23,305
26,017
23,759
11,443
14,928
18,496
16,897
15,909
17,748
23,944
23,956
21,803
31,676
29,428
32,290
24,761
61,060
29,624
34,441
27,429
26,463
44,689
36,649
20,318
18,252
23,628
16,653
15,421
8,364
8,074
6,411
5,583
4,905
5,180
7,777
6,645
7,616
8,874
9,584
7,268
7,822
6,381
3,580
1,020
1,435
2,736
11,598
11,507
14,900
11,600
8,700
17,000
24,100
17,900
9,200
6,200
6,900
3,600
4,300
4,500
4,900
6,800
6,800
3,400
1,400
4,300
3,700
3,700
4,176
5,525
4,956
4,846
5,337
4,635
4,721
7,481
5,793
9,528
6,732
7,578
4,998
7,287
7,505
5,900
5,939
9,809
11,675
8,179
7,854
6,979
7,333
3,803
3,8037,3336,9797,8548,17911,6759,8095,9395,9007,5057,2874,9987,5786,7329,5285,7937,4814,7214,6355,3374,8464,9565,5254,1763,7003,7004,3001,4003,4006,8006,8004,9004,5004,3003,6006,9006,2009,20017,90024,10017,0008,70011,60014,90011,50711,5982,7361,4351,0203,5806,3817,8227,2689,5848,8747,6166,6457,7775,1804,9055,5836,4118,0748,36415,42116,65323,62818,25220,31836,64944,68926,46327,42934,44129,62461,06024,76132,29029,42831,67621,80323,95623,94417,74815,90916,89718,49614,92811,44323,75926,01723,30515,17721,35914,34519,85616,00426,17822,80024,20024,10030,70017,80018,20018,70017,30013,80014,90015,80022,50024,20020,40015,90015,90010,10010,70010,20010,4009,80010,3006,9006,2004,3004,7004,5004,6003,6002,2003,0001,7001,1009008001,4002,9002,1002,1001,6001,8001,60004,2000004,3000004,1000003,9000
   > Long-term Liabilities 
0
2,000
0
0
0
1,100
0
0
0
200
0
0
0
7,600
0
3,000
3,800
5,200
5,000
6,400
6,800
800
800
600
700
4,400
22,400
23,000
6,400
22,400
21,600
22,300
16,000
21,000
27,500
26,300
27,200
19,500
18,100
27,000
35,000
26,100
26,100
81,500
81,300
81,500
91,500
95,200
114,700
115,200
117,300
108,500
109,900
118,300
109,500
105,500
101,500
113,493
113,198
114,889
109,877
108,811
107,632
102,219
78,711
78,690
166
418
394
5,236
5,212
15,913
38,176
28,929
20,908
24,183
20,226
19,444
11,503
121,940
125,810
120,468
109,726
109,627
109,628
109,551
110,184
109,640
109,686
71,738
71,766
40,989
34,179
15,202
15,423
5,775
5,862
26,133
37,263
36,631
36,000
35,368
34,737
34,106
33,474
32,842
32,211
31,579
30,948
275
296
200
300
200
200
200
100
100
100
900
800
700
500
17,300
17,700
18,000
17,000
15,400
15,500
15,600
16,100
17,630
16,612
16,622
16,514
15,183
13,928
14,638
14,906
13,830
12,457
12,730
17,415
17,989
16,282
23,593
22,854
22,978
22,434
31,262
25,329
24,415
23,697
22,853
20,301
20,30122,85323,69724,41525,32931,26222,43422,97822,85423,59316,28217,98917,41512,73012,45713,83014,90614,63813,92815,18316,51416,62216,61217,63016,10015,60015,50015,40017,00018,00017,70017,30050070080090010010010020020020030020029627530,94831,57932,21132,84233,47434,10634,73735,36836,00036,63137,26326,1335,8625,77515,42315,20234,17940,98971,76671,738109,686109,640110,184109,551109,628109,627109,726120,468125,810121,94011,50319,44420,22624,18320,90828,92938,17615,9135,2125,23639441816678,69078,711102,219107,632108,811109,877114,889113,198113,493101,500105,500109,500118,300109,900108,500117,300115,200114,70095,20091,50081,50081,30081,50026,10026,10035,00027,00018,10019,50027,20026,30027,50021,00016,00022,30021,60022,4006,40023,00022,4004,4007006008008006,8006,4005,0005,2003,8003,00007,6000002000001,1000002,0000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
0
300
0
200
0
0
0
100
0
0
2,696
2,321
1,944
1,562
1,175
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,1751,5621,9442,3212,69600100000200030005000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,427
2,563
0
0
0
0
900
800
0
0
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000005000080090000002,5632,4270000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
0
1,260
0
17,000
0
3,280
16,900
0
15,400
15,500
0
14,561
13,916
14,301
14,570
13,309
12,537
12,944
13,434
12,559
11,337
11,698
14,929
15,061
11,919
12,196
10,857
11,141
10,865
12,358
5,852
0
5,131
0
0
005,13105,85212,35810,86511,14110,85712,19611,91915,06114,92911,69811,33712,55913,43412,94412,53713,30914,57014,30113,91614,561015,50015,400016,9003,280017,00001,260010000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,106
33,474
32,842
32,211
31,579
30,948
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,800
17,200
17,600
0
16,700
15,300
15,400
16,000
14,561
13,916
14,301
14,413
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000014,41314,30113,91614,56116,00015,40015,30016,700017,60017,20016,8000000000000000030,94831,57932,21132,84233,47434,1060000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
2,700
0
0
0
6,100
0
0
0
8,000
0
0
0
8,300
0
8,800
9,300
9,700
10,300
10,800
11,500
12,100
13,000
13,700
14,100
15,100
10,600
11,400
14,200
13,900
14,700
15,500
16,500
18,000
27,600
30,400
32,500
51,800
54,800
58,300
61,700
69,400
69,400
73,400
74,800
86,100
87,400
89,400
81,500
75,700
73,800
73,300
69,800
54,200
53,500
54,500
56,100
58,200
61,919
64,972
74,148
77,394
78,135
80,336
182,220
187,206
186,145
187,458
188,307
189,029
189,844
187,410
231,067
319,316
317,363
309,396
299,849
284,321
269,719
250,716
236,289
161,827
144,391
131,318
113,079
111,388
100,967
97,632
83,150
146,532
124,719
125,347
124,230
121,382
114,611
106,154
99,628
97,407
94,293
64,626
64,662
60,570
63,418
59,696
60,687
58,871
59,410
57,335
29,967
78,962
80,104
68,000
64,900
64,200
96,000
86,900
77,900
82,400
81,500
69,500
63,500
57,500
52,700
46,200
36,600
28,000
24,200
18,700
18,700
13,900
10,800
31,106
22,353
15,988
11,238
12,576
15,845
18,903
12,952
31,293
40,235
131,678
123,404
176,235
199,782
204,948
187,531
166,365
143,094
122,307
110,597
89,753
85,073
71,521
57,805
57,80571,52185,07389,753110,597122,307143,094166,365187,531204,948199,782176,235123,404131,67840,23531,29312,95218,90315,84512,57611,23815,98822,35331,10610,80013,90018,70018,70024,20028,00036,60046,20052,70057,50063,50069,50081,50082,40077,90086,90096,00064,20064,90068,00080,10478,96229,96757,33559,41058,87160,68759,69663,41860,57064,66264,62694,29397,40799,628106,154114,611121,382124,230125,347124,719146,53283,15097,632100,967111,388113,079131,318144,391161,827236,289250,716269,719284,321299,849309,396317,363319,316231,067187,410189,844189,029188,307187,458186,145187,206182,22080,33678,13577,39474,14864,97261,91958,20056,10054,50053,50054,20069,80073,30073,80075,70081,50089,40087,40086,10074,80073,40069,40069,40061,70058,30054,80051,80032,50030,40027,60018,00016,50015,50014,70013,90014,20011,40010,60015,10014,10013,70013,00012,10011,50010,80010,3009,7009,3008,80008,3000008,0000006,1000002,7000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
3,500
3,500
3,572
3,599
3,775
3,783
3,787
3,804
3,806
3,845
3,859
3,870
3,871
3,895
3,910
3,958
4,724
5,773
5,817
5,913
5,917
5,943
5,959
5,984
6,006
6,032
6,039
6,119
6,121
6,149
6,145
6,190
6,190
6,212
6,216
6,228
6,229
6,239
6,247
6,271
6,271
6,278
6,283
6,315
6,315
6,321
6,327
6,355
6,358
6,359
6,357
6,357
6,357
3,422
3,422
2,800
2,800
2,800
3,500
3,500
3,500
3,500
3,500
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
714
714
714
714
834
1,579
4,622
5
7,200
10
11
11
12
12
13
13
13
13
13
13
14
15
15
0
015151413131313131312121111107,20054,6221,5798347147147147143,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,5003,5003,5003,5003,5002,8002,8002,8003,4223,4226,3576,3576,3576,3596,3586,3556,3276,3216,3156,3156,2836,2786,2716,2716,2476,2396,2296,2286,2166,2126,1906,1906,1456,1496,1216,1196,0396,0326,0065,9845,9595,9435,9175,9135,8175,7734,7243,9583,9103,8953,8713,8703,8593,8453,8063,8043,7873,7833,7753,5993,5723,5003,5003,5000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity00-374,799-352,249-327,109-303,191-273,882-244,452-219,351-198,587-181,004-164,888-148,8810-126,935-117,958-116,661-110,252-104,992-99,355-97,989-93,087-86,539-77,668-172,500-169,100-163,800-163,800-157,800-153,400-144,300-134,300-127,300-122,100-115,500-108,900-89,000-90,200-96,700-89,800-79,600-82,800-82,500-78,600-72,098-72,313-235,337-231,247-228,514-228,078-226,088-226,1660000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-3,200
0
0
0
-3,500
0
0
0
-4,000
0
0
0
-4,500
0
-4,500
-4,500
-5,100
-5,100
-5,100
-5,100
-5,800
-5,800
-5,800
-5,800
-6,700
-7,100
-7,100
-7,100
-500
-500
-500
-500
-8,600
-8,600
-8,600
-8,600
-9,200
-9,200
-9,200
-9,200
-16,400
-16,400
-18,400
-18,400
-20,400
-21,400
-21,400
-21,400
-24,800
-24,800
-28,300
-28,300
-12,900
-12,900
-800
-700
-12,900
0
0
0
0
-35,441
-35,441
0
0
0
0
0
0
0
0
0
0
8
1
-30
-303
-228
-50
99
171
-11
-363
-304
0
-66,233
-66,233
0
0
0
0
0
60
200
-2
0
-20
0
8
13
-3
1
3
-1
-4,236
-4,236
30,000
0
30,517
31,053
25,300
25,600
24,600
25,900
26,800
24,300
21,700
19,000
18,900
18,900
18,900
18,900
19,000
19,000
19,000
19,000
19,000
19,000
19,000
19,000
-1,334
-1,455
-1,522
-1,570
-1,700
-1,825
-1,956
-459
-478
-503
-537
0
-5
-9
-3
-74
-309
-409
-518
-299
-70
-24
-11
0
0-11-24-70-299-518-409-309-74-3-9-50-537-503-478-459-1,956-1,825-1,700-1,570-1,522-1,455-1,33419,00019,00019,00019,00019,00019,00019,00019,00018,90018,90018,90018,90019,00021,70024,30026,80025,90024,60025,60025,30031,05330,517030,000-4,236-4,236-131-31380-200-22006000000-66,233-66,2330-304-363-1117199-50-228-303-30180000000000-35,441-35,4410000-12,900-700-800-12,900-12,900-28,300-28,300-24,800-24,800-21,400-21,400-21,400-20,400-18,400-18,400-16,400-16,400-9,200-9,200-9,200-9,200-8,600-8,600-8,600-8,600-500-500-500-500-7,100-7,100-7,100-6,700-5,800-5,800-5,800-5,800-5,100-5,100-5,100-5,100-4,500-4,5000-4,500000-4,000000-3,500000-3,2000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
372,071
372,985
373,157
374,134
374,792
375,995
234,384
234,775
118,700
119,000
119,600
146,200
146,400
146,800
147,400
148,000
155,600
156,200
156,800
157,200
157,600
158,000
158,500
159,100
159,600
159,600
160,100
160,400
108,060
108,178
108,361
108,513
111,097
119,258
124,533
124,788
142,051
167,160
0
272,274
341,116
380,783
403,525
406,943
411,113
417,372
426,003
437,992
442,068
459,912
0
0
00459,912442,068437,992426,003417,372411,113406,943403,525380,783341,116272,2740167,160142,051124,788124,533119,258111,097108,513108,361108,178108,060160,400160,100159,600159,600159,100158,500158,000157,600157,200156,800156,200155,600148,000147,400146,800146,400146,200119,600119,000118,700234,775234,384375,995374,792374,134373,157372,985372,0710000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000-117,048-117,048-117,048-92,567-92,567-92,567-92,567-92,5670000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
9,300
0
0
0
10,800
0
0
0
11,800
0
0
0
11,800
0
-2,200
11,900
11,700
11,800
11,800
11,800
11,800
12,200
12,300
12,200
12,600
7,600
8,000
11,800
12,100
12,400
12,500
12,500
12,600
20,600
21,300
21,300
39,600
39,600
39,600
39,600
136,500
136,500
138,300
138,600
139,900
139,900
139,900
139,900
140,700
140,700
140,700
141,000
140,900
140,700
138,000
138,000
138,100
141,060
142,799
152,300
152,642
152,694
153,363
154,209
157,710
157,296
157,777
157,800
157,428
157,679
158,196
198,894
292,669
295,503
305,024
306,426
308,197
309,326
311,050
312,570
313,589
314,405
316,428
319,941
321,907
322,517
323,916
325,307
309,919
294,341
295,333
295,930
320,816
321,108
318,438
318,892
315,574
306,955
280,654
275,550
277,799
278,658
279,504
280,418
280,590
281,567
282,225
258,947
117,336
117,727
118,700
119,000
119,600
146,200
146,400
146,800
147,400
148,000
155,600
156,200
156,800
157,200
157,600
158,000
158,500
159,100
19,000
159,600
160,100
160,400
108,060
108,178
108,361
108,513
111,097
119,258
124,533
129,608
142,051
167,160
266,687
272,274
341,116
380,783
403,525
406,943
411,113
417,372
426,003
437,992
442,058
459,881
463,716
0
0463,716459,881442,058437,992426,003417,372411,113406,943403,525380,783341,116272,274266,687167,160142,051129,608124,533119,258111,097108,513108,361108,178108,060160,400160,100159,60019,000159,100158,500158,000157,600157,200156,800156,200155,600148,000147,400146,800146,400146,200119,600119,000118,700117,727117,336258,947282,225281,567280,590280,418279,504278,658277,799275,550280,654306,955315,574318,892318,438321,108320,816295,930295,333294,341309,919325,307323,916322,517321,907319,941316,428314,405313,589312,570311,050309,326308,197306,426305,024295,503292,669198,894158,196157,679157,428157,800157,777157,296157,710154,209153,363152,694152,642152,300142,799141,060138,100138,000138,000140,700140,900141,000140,700140,700140,700139,900139,900139,900139,900138,600138,300136,500136,50039,60039,60039,60039,60021,30021,30020,60012,60012,50012,50012,40012,10011,8008,0007,60012,60012,20012,30012,20011,80011,80011,80011,80011,70011,900-2,200011,80000011,80000010,8000009,3000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,379
Cost of Revenue-0
Gross Profit07,379
 
Operating Income (+$)
Gross Profit0
Operating Expense-90,726
Operating Income-83,347-90,726
 
Operating Expense (+$)
Research Development68,142
Selling General Administrative22,584
Selling And Marketing Expenses0
Operating Expense90,72690,726
 
Net Interest Income (+$)
Interest Income2,652
Interest Expense-1,447
Other Finance Cost-0
Net Interest Income1,205
 
Pretax Income (+$)
Operating Income-83,347
Net Interest Income1,205
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-82,204-83,285
EBIT - interestExpense = -1,447
-82,465
-81,018
Interest Expense1,447
Earnings Before Interest and Taxes (EBIT)0-80,757
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-82,204
Tax Provision-261
Net Income From Continuing Ops-82,465-82,465
Net Income-82,465
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-62-1,205
 

Technical Analysis of Vaxart
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vaxart. The general trend of Vaxart is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vaxart's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vaxart Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.54 < 1.59 < 1.725.

The bearish price targets are: 1.29 > 1.07 > 1.03.

Tweet this
Vaxart Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vaxart Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vaxart Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vaxart Inc. The current macd is 0.03358245.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaxart price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vaxart. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vaxart price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vaxart Inc Daily Moving Average Convergence/Divergence (MACD) ChartVaxart Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vaxart Inc. The current adx is 20.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vaxart shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Vaxart Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vaxart Inc. The current sar is 1.06969374.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vaxart Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vaxart Inc. The current rsi is 61.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vaxart Inc Daily Relative Strength Index (RSI) ChartVaxart Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vaxart Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vaxart price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vaxart Inc Daily Stochastic Oscillator ChartVaxart Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vaxart Inc. The current cci is 185.98.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vaxart Inc Daily Commodity Channel Index (CCI) ChartVaxart Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vaxart Inc. The current cmo is 30.56.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vaxart Inc Daily Chande Momentum Oscillator (CMO) ChartVaxart Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vaxart Inc. The current willr is -28.94736842.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vaxart is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vaxart Inc Daily Williams %R ChartVaxart Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vaxart Inc.

Vaxart Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vaxart Inc. The current atr is 0.09159599.

Vaxart Inc Daily Average True Range (ATR) ChartVaxart Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vaxart Inc. The current obv is -67,219,752.

Vaxart Inc Daily On-Balance Volume (OBV) ChartVaxart Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vaxart Inc. The current mfi is 72.60.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vaxart Inc Daily Money Flow Index (MFI) ChartVaxart Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vaxart Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vaxart Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vaxart Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.562
Ma 20Greater thanMa 501.194
Ma 50Greater thanMa 1001.143
Ma 100Greater thanMa 2000.910
OpenGreater thanClose1.330
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vaxart with someone you think should read this too:
  • Are you bullish or bearish on Vaxart? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vaxart? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vaxart Inc

I send you an email if I find something interesting about Vaxart Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vaxart Inc.

Receive notifications about Vaxart Inc in your mailbox!